SCHEMBL8907005

SCHEMBL8907005

CC([O])OCCc1ccccn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.49
ALDH1A1 P00352 4/20 0.49
CYP2C19 P33261 2/20 0.49
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
HRH3 Q9Y5N1 1/20 0.47
HRH1 P35367 2/20 0.47
LMNA P02545 2/20 0.46
TAAR1 Q96RJ0 1/20 0.46
ALOX15 P16050 1/20 0.46
TDP1 Q9NUW8 1/20 0.44
HSD17B10 Q99714 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1826440 0.86 CYP1A2 (0.51) CYP1A2ALDH1A1CYP2C19CA12CA1
SCHEMBL25610981 0.83 CYP1A2 (0.49) CYP1A2ALDH1A1CYP2C19CA12CA1
SCHEMBL19951056 0.80 ALDH1A1 (0.46) CYP1A2ALDH1A1CYP2C19CA12CA1
SCHEMBL12414711 0.77 CA12 (0.56) CYP1A2ALDH1A1CYP2C19CA12CA1
SCHEMBL172462 0.76 ALDH1A1 (0.47) CYP1A2ALDH1A1CYP2C19CA12CA1
SCHEMBL12530835 0.76 HRH1 (0.50) CYP1A2ALDH1A1CYP2C19CA12CA1
SCHEMBL2608874 0.76 ALDH1A1 (0.53) CYP1A2ALDH1A1CYP2C19CA12CA1
SCHEMBL30201139 0.76 CYP1A2 (0.61) CYP1A2ALDH1A1CYP2C19CA12CA1
Metyridine SCHEMBL30481621 0.76 HRH1 (0.55) CYP1A2ALDH1A1CYP2C19CA12CA1
SCHEMBL574013 0.76 CYP1A2 (0.61) CYP1A2ALDH1A1CYP2C19CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5659065-A CHEMICAL INTERMEDIATES FOR MEDICINAL ACTIVE AGENTS NOVARTIS CORPORATION (US) 1997-08-19 US disclosed
EP-0678500-A1 Alpha-amino alkanoic acids and reduction products as intermediates in the preparation of renin inhibitors CIBA-GEIGY AG (CH) 1995-10-25 EP disclosed